1
/
of
0
FDA Drug Approval, N203756, COMETRIQ
FDA Drug Approval, N203756, COMETRIQ
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 203756
Company: EXELIXIS
Drug Name: COMETRIQ
Active Ingredients: CABOZANTINIB S-MALATE
Strength: EQ 80MG BASE
Dosage Form/Route: CAPSULE;ORAL
Action Date: 11/29/2012
Marketing Status: Prescription
Submission Classification: Type 1 - New Molecular Entity
Company: EXELIXIS
Drug Name: COMETRIQ
Active Ingredients: CABOZANTINIB S-MALATE
Strength: EQ 80MG BASE
Dosage Form/Route: CAPSULE;ORAL
Action Date: 11/29/2012
Marketing Status: Prescription
Submission Classification: Type 1 - New Molecular Entity
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details